Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 1. Indole-3-acetamides
Citations Over Time
Abstract
Phospholipases (PLAs) produce rate-limiting precursors in the biosynthesis of various types of biologically active lipids involved in inflammatory processes. Increased levels of human nonpancreatic secretory phospholipase A2 (hnps-PLA2) have been detected in several pathological conditions. An inhibitor of this enzyme could have therapeutic utility. A broad screening program was carried out to identify chemical structures which could inhibit hnps-PLA2. One of the lead compounds generated by the screening program was 5-methoxy-2-methyl-1-(phenylmethyl)-1H-indole-3-acetic acid (13a). We describe the syntheses, structure−activity relationships, and pharmacological activities of a series of indole-3-acetamides and related compounds derived from this lead. This SAR was undertaken with the aid of X-ray crystal structures of complexes between the inhibitors and hnps-PLA2 which were of great value in directing the SAR.
Related Papers
- → Group-Specific Assays That Distinguish between the Four Major Types of Mammalian Phospholipase A2(1999)150 cited
- → Inhibition of the complete set of mammalian secreted phospholipases A2 by indole analogues(2004)52 cited
- → Synthesis and evaluation of the anti-proliferative activity of diaryl-3-pyrrolin-2-ones and fused analogs(2016)22 cited
- → The structure-activity relationships of a series of suicide inhibitors of phospholipase A2(1998)2 cited
- → Synthesis of benzophenone oxime analogues as inhibitor of secretory phospholipase A2 with anti-inflammatory activity(2004)